Exploiting the natural properties of extracellular vesicles in targeted delivery towards specific cells and tissues
Author
dc.contributor.author
Lara, Pablo
Author
dc.contributor.author
Chan, Alan B.
Author
dc.contributor.author
Cruz, Luis J.
Author
dc.contributor.author
Quest, Andrew F. G.
Author
dc.contributor.author
Kogan, Marcelo J.
Admission date
dc.date.accessioned
2021-05-19T15:53:02Z
Available date
dc.date.available
2021-05-19T15:53:02Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Pharmaceutics 2020, 12, 1022
es_ES
Identifier
dc.identifier.other
10.3390/pharmaceutics12111022
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/179662
Abstract
dc.description.abstract
Extracellular vesicles (EVs) are important mediators of intercellular communication that participate in many physiological/pathological processes. As such, EVs have unique properties related to their origin, which can be exploited for drug delivery applications in cell regeneration, immunosuppression, inflammation, cancer treatment or cardioprotection. Moreover, their cell-like membrane organization facilitates uptake and accumulation in specific tissues and organs, which can be exploited to improve selectivity of cargo delivery. The combination of these properties with the inclusion of drugs or imaging agents can significantly improve therapeutic efficacy and selectivity, reduce the undesirable side effects of drugs or permit earlier diagnosis of diseases. In this review, we will describe the natural properties of EVs isolated from different cell sources and discuss strategies that can be applied to increase the efficacy of targeting drugs or other contents to specific locations. The potential risks associated with the use of EVs will also be addressed.
es_ES
Patrocinador
dc.description.sponsorship
European Commission
777682
734684
872391
872860
807281
852985
Agencia Nacional de Investigacion y Desarrollo (ANID) Chile grant FONDECYT
1170925
Agencia Nacional de Investigacion y Desarrollo (ANID) Chile grant FONDAP
15130011